JP2014518063A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518063A5
JP2014518063A5 JP2014513625A JP2014513625A JP2014518063A5 JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5 JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5
Authority
JP
Japan
Prior art keywords
crosslinker
peptide
modified
igf
lysosomal enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014513625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518063A (ja
JP6300720B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039705 external-priority patent/WO2012166653A2/en
Publication of JP2014518063A publication Critical patent/JP2014518063A/ja
Publication of JP2014518063A5 publication Critical patent/JP2014518063A5/ja
Application granted granted Critical
Publication of JP6300720B2 publication Critical patent/JP6300720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014513625A 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 Active JP6300720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490957P 2011-05-27 2011-05-27
US61/490,957 2011-05-27
PCT/US2012/039705 WO2012166653A2 (en) 2011-05-27 2012-05-25 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017133655A Division JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Publications (3)

Publication Number Publication Date
JP2014518063A JP2014518063A (ja) 2014-07-28
JP2014518063A5 true JP2014518063A5 (https=) 2018-02-15
JP6300720B2 JP6300720B2 (ja) 2018-03-28

Family

ID=47260229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014513625A Active JP6300720B2 (ja) 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法
JP2017133655A Pending JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017133655A Pending JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Country Status (21)

Country Link
US (2) US9545450B2 (https=)
EP (1) EP2714752B1 (https=)
JP (2) JP6300720B2 (https=)
KR (2) KR101955054B1 (https=)
CN (2) CN104160033B (https=)
BR (1) BR112013030432A2 (https=)
CA (1) CA2836318C (https=)
CY (1) CY1120485T1 (https=)
DK (1) DK2714752T3 (https=)
ES (1) ES2660185T3 (https=)
HR (1) HRP20180291T1 (https=)
HU (1) HUE038172T2 (https=)
LT (1) LT2714752T (https=)
NO (1) NO2820016T3 (https=)
PL (1) PL2714752T3 (https=)
PT (1) PT2714752T (https=)
RS (1) RS56913B1 (https=)
SI (1) SI2714752T1 (https=)
SM (1) SMT201800101T1 (https=)
TR (1) TR201802230T4 (https=)
WO (1) WO2012166653A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925303B2 (en) 2012-11-13 2018-03-27 Edwards Lifesciences Corporation Methods for cross-linking bioprosthetic tissue using bio-orthogonal binding pairs
CN105189742A (zh) * 2013-03-15 2015-12-23 阿米库斯治疗学公司 化学交联剂
JP6800752B2 (ja) * 2014-04-04 2020-12-16 ベスタロン コーポレイション 人工的に活性化したペプチド
US10722559B2 (en) * 2014-08-11 2020-07-28 Shire Human Genetic Therapies, Inc. Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
WO2016054231A1 (en) * 2014-09-30 2016-04-07 Amicus Therapeutics, Inc. Highly potent acid alpha-glucosidase with enhanced carbohydrates
CN104356238B (zh) * 2014-10-15 2018-01-09 大连理工大学 一种重组蛋白a亲和配基的定点固定化方法
KR102322182B1 (ko) * 2015-03-11 2021-11-08 오웬스 코닝 인텔렉츄얼 캐피탈 엘엘씨 섬유성 재료로 머플러들을 충전하기 위한 방법들 및 시스템들
AU2016349528A1 (en) 2015-11-06 2018-05-17 Biomarin Pharmaceutical Inc. Cell-based assays for detection of antibodies or other factors that neutralize uptake of lysosomal enzymes
AU2016365834B2 (en) * 2015-12-08 2023-09-28 Regeneron Pharmaceuticals, Inc. Compositions and methods for internalizing enzymes
FI3635009T3 (fi) 2017-06-07 2026-04-07 Regeneron Pharma Koostumuksia ja menetelmiä entsyymien internalisoimiseksi
BR112019026434A2 (pt) 2017-06-14 2020-07-14 Virometix Ag peptídeos cíclicos para proteção contra vírus sincicial respiratório
AU2018345303B2 (en) 2017-10-02 2025-09-18 Denali Therapeutics Inc. Fusion proteins comprising enzyme replacement therapy enzymes
JP7779653B2 (ja) 2018-02-07 2025-12-03 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 治療用タンパク質送達のための方法および組成物
WO2019173638A1 (en) * 2018-03-08 2019-09-12 California Institute Of Technology Sample multiplexing for single-cell rna sequencing
KR20210005154A (ko) 2018-04-30 2021-01-13 아미쿠스 세라퓨틱스, 인코포레이티드 유전자 요법 작제물 및 사용 방법
EP3793591A1 (en) 2018-05-17 2021-03-24 Regeneron Pharmaceuticals, Inc. Anti-cd63 antibodies, conjugates, and uses thereof
AR116624A1 (es) 2018-10-10 2021-05-26 Amicus Therapeutics Inc Composiciones de polipéptidos estabilizados por enlaces disulfuro y métodos de uso
JP7703446B2 (ja) * 2018-11-28 2025-07-07 プロメガ コーポレイション 反応性ペプチド標識付け
CN113301925A (zh) 2018-12-19 2021-08-24 小利兰·斯坦福大学理事会 用于溶酶体靶向的双官能分子以及相关的组合物和方法
EP3897708A1 (en) 2018-12-20 2021-10-27 Virometix AG Lipopeptide building blocks and synthetic virus-like particles
CN114127275A (zh) * 2019-04-30 2022-03-01 宾夕法尼亚州大学信托人 可用于治疗庞贝病的组合物
CN110373405B (zh) * 2019-07-24 2023-12-15 杭州恩和生物科技有限公司 一种接枝聚合物的生物酶及其制备方法和固定方法
CN115087458A (zh) * 2019-10-10 2022-09-20 阿米库斯治疗学公司 变体igf2构建体
WO2022063990A1 (en) 2020-09-28 2022-03-31 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination
TW202237850A (zh) 2020-12-01 2022-10-01 賓州大學委員會 具有組織特異性靶向基序的新穎構成物及含有其之組成物
AR125406A1 (es) 2021-04-23 2023-07-12 Univ Pennsylvania Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen
US20240279360A1 (en) 2021-06-23 2024-08-22 Lycia Therapeutics, Inc. Bifunctional compounds containing igf-2 polypeptides
AU2022310356A1 (en) 2021-07-14 2024-01-25 Lycia Therapeutics, Inc. Asgpr cell surface receptor binding compounds and conjugates
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
KR20250135916A (ko) 2022-12-17 2025-09-15 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심장 및 골격근 특이적 표적화 모티프를 갖는 재조합 aav 돌연변이체 벡터 및 이를 포함하는 조성물
AR133098A1 (es) 2023-06-29 2025-08-27 Univ Pennsylvania Aav mutante con motivos dirigidos al sistema nervioso central y composiciones que lo contienen
KR20260040241A (ko) 2023-07-12 2026-03-24 비로메틱스 아게 폐렴구균 항원의 조성물
WO2025106661A1 (en) 2023-11-14 2025-05-22 The Trustees Of The University Of Pennsylvania Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1118334A1 (en) 2000-01-11 2001-07-25 Aventis Behring Gesellschaft mit beschränkter Haftung Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
US7355018B2 (en) 2003-09-30 2008-04-08 Regeneron Pharmaceuticals, Inc. Modified IGF1 polypeptides with increased stability and potency
HRP20170698T1 (hr) * 2008-05-07 2017-09-22 Biomarin Pharmaceutical Inc. Lizosomski usmjereni peptidi i njihove uporabe
EP3912643B8 (en) * 2009-02-13 2023-08-23 Immunomedics, Inc. Immunoconjugates with an intracellularly-cleavable linkage

Similar Documents

Publication Publication Date Title
JP2014518063A5 (https=)
JP2017225444A5 (https=)
CA2836318C (en) Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
CA2052375C (en) Parathyroid hormone derivatives
CN101133082B (zh) 酰化的glp-1化合物
WO2013065009A1 (en) A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly
JP2015534568A (ja) Irf5に結合する細胞透過性ペプチド
MX2011000847A (es) Proteinas conjugadas con eficacia prolongada in vivo.
KR20100014215A (ko) 신규 단백질 접합체 및 그것의 제조 방법
CA2635998A1 (fr) Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
CN117304281B (zh) 一种重组rsv f蛋白及其应用
AU2012300934A1 (en) Cyclosporin derivatives
KR20150124999A (ko) 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물
JP2014506450A5 (https=)
KR20150132126A (ko) 화학적 가교결합제
CN109384839B (zh) 胰高血糖素样肽-1类似物及其用途
JPH02500517A (ja) ペプチド化合物
WO2014082080A2 (en) Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
JPS6084298A (ja) 新規生理活性ポリペプチドおよびその製造法
CN108341880A (zh) 含有胰高血糖素样肽-1和胰高血糖素的片段类似物的嵌合多肽及其用途
EP3210995B1 (en) Hemagglutinin-binding peptide
CN103288968B (zh) 一种抗肿瘤靶向复合物及其制备方法和应用
CN108341879A (zh) 一种嵌合多肽及其用途
ES2537701T3 (es) Un método de hidrólisis de péptidos, uso de una composición como agente bacteriostático y bactericida y los usos de la forma activa de LytM de S. aureus
JP2024510906A (ja) 重症筋無力症の治療的又は予防的処置用のワクチン